日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Anaplastic Lymphoma Kinase (ALK) Inhibitors Enhance Phagocytosis Induced by CD47 Blockade in Sensitive and Resistant ALK-Driven Malignancies

间变性淋巴瘤激酶 (ALK) 抑制剂可增强 CD47 阻断诱导的对 ALK 敏感和耐药的恶性肿瘤的吞噬作用

期刊:Biomedicines
影响因子:3.9
doi:10.3390/biomedicines12122819
Malighetti, Federica; Villa, Matteo; Mauri, Mario; Piane, Simone; Crippa, Valentina; Crespiatico, Ilaria; Cocito, Federica; Bossi, Elisa; Steidl, Carolina; Civettini, Ivan; Scollo, Chiara; Ramazzotti, Daniele; Gambacorti-Passerini, Carlo; Piazza, Rocco; Mologni, Luca; Aroldi, Andrea
信号转导
T细胞
CD47
CD4
肿瘤
淋巴瘤
肿瘤免疫
ALK
发表日期：2024
文献求助 收藏

Evolutionary signatures of human cancers revealed via genomic analysis of over 35,000 patients

通过对超过35000名患者的基因组分析，揭示了人类癌症的进化特征

期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-023-41670-3
Fontana, Diletta; Crespiatico, Ilaria; Crippa, Valentina; Malighetti, Federica; Villa, Matteo; Angaroni, Fabrizio; De Sano, Luca; Aroldi, Andrea; Antoniotti, Marco; Caravagna, Giulio; Piazza, Rocco; Graudenzi, Alex; Mologni, Luca; Ramazzotti, Daniele
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

Characterization of SARS-CoV-2 Mutational Signatures from 1.5+ Million Raw Sequencing Samples

对超过150万份原始测序样本中的SARS-CoV-2突变特征进行表征

期刊:Viruses-Basel
影响因子:3.5
doi:10.3390/v15010007
Aroldi, Andrea; Angaroni, Fabrizio; D'Aliberti, Deborah; Spinelli, Silvia; Crespiatico, Ilaria; Crippa, Valentina; Piazza, Rocco; Graudenzi, Alex; Ramazzotti, Daniele
SARS-CoV-2
发表日期：2022
文献求助 收藏

An Imatinib-non-responsive patient with an ABL Leu387Trp mutation achieves cytogenetic and molecular response under bosutinib: Case report and biological characterization.

一例对伊马替尼无反应且携带 ABL Leu387Trp 突变的患者在接受博舒替尼治疗后获得细胞遗传学和分子学缓解：病例报告和生物学特征分析

期刊:Clinical Case Reports
影响因子:0.6
doi:10.1002/ccr3.2531
Crespiatico Ilaria, Bossi Elisa, Brioschi Filippo, Piazza Rocco, Mologni Luca, Gambacorti-Passerini Carlo
细胞生物学
发表日期：2020
文献求助 收藏